WIN-Partners Co., Ltd., through its subsidiaries, engages in the sales of medical equipment in Japan. The company offers PTCA balloon catheters and intravascular ultrasound diagnostic catheters for Ischemic heart disease-related; cardiac rhythm management, includes space makers, implantable cardioverter-defibrillators, implantable cardioverter-defibrillators with biventricular pacing, catheters for electrophysiological testing, and catheters for myocardial ablation; and stent grafts, transcatheter bioprosthetic valves, artificial blood vessels, heart-lung machines for cardiovascular surgery. It also provides PTA balloon catheters, peripheral vascular stents, and embolization coils to treat peripheral vascular and cerebrovascular diseases; and brain surgery-related products. In addition, the company offers various medical equipment such as X-ray angiography equipment, computed tomography equipment, magnetic resonance imaging equipment, and anesthesia machines; insulin pump, continuous glucose monitor, blood pressure transducer set, and blood pressure monitoring tubing. WIN-Partners Co., Ltd. was incorporated in 2013 and is headquartered in Chuo, Japan.
Research context
WIN-Partners Co., Ltd appears in PyInvesting’s Tokyo Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- JPY
- Sector
- Healthcare
- Industry
- Medical Distribution
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
WIN-Partners Co., Ltd is currently in a long term downtrend where the price is trading 9.6% below its 200 day moving average.
From a valuation standpoint, the stock is 99.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.5.
WIN-Partners Co., Ltd's total revenue rose by 7.4% to $17B since the same quarter in the previous year.
Its net income has increased by 5.0% to $423M since the same quarter in the previous year.
Based on the above factors, WIN-Partners Co., Ltd gets an overall score of 3/5.